Cargando…

Diagnostic potential of tumor DNA from ovarian cyst fluid

We determined whether the mutations found in ovarian cancers could be identified in the patients' ovarian cyst fluids. Tumor-specific mutations were detectable in the cyst fluids of 19 of 23 (83%) borderline tumors, 10 of 13 (77%) type I cancers, and 18 of 18 (100%) type II cancers. In contrast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuxuan, Sundfeldt, Karin, Mateoiu, Constantina, Shih, Ie-Ming, Kurman, Robert J, Schaefer, Joy, Silliman, Natalie, Kinde, Isaac, Springer, Simeon, Foote, Michael, Kristjansdottir, Björg, James, Nathan, Kinzler, Kenneth W, Papadopoulos, Nickolas, Diaz, Luis A, Vogelstein, Bert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2016
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946896/ https://www.ncbi.nlm.nih.gov/pubmed/27421040 http://dx.doi.org/10.7554/eLife.15175

Ejemplares similares

Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation assay
por: Mateoiu, Constantina, et al.
Publicado: (2021)

FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
por: Kinde, Isaac, et al.
Publicado: (2012)

Early inflammatory response in epithelial ovarian tumor cyst fluids
por: Kristjánsdóttir, Björg, et al.
Publicado: (2014)

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
por: Springer, Simeon U, et al.
Publicado: (2018)

Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
por: Springer, Simeon U, et al.
Publicado: (2018)

Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
por: Kristjansdottir, Björg, et al.
Publicado: (2013)

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study
por: Maritschnegg, Elisabeth, et al.
Publicado: (2015)

Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
por: Kristjansdottir, Björg, et al.
Publicado: (2012)

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
por: Partheen, Karolina, et al.
Publicado: (2011)

Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
por: Levan, Kristina, et al.
Publicado: (2017)

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma
por: Mattox, Austin K, et al.
Publicado: (2022)

Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers
por: Lycke, Maria, et al.
Publicado: (2020)

Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors
por: Barone, Angela, et al.
Publicado: (2020)

Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer
por: Liljedahl, Leena, et al.
Publicado: (2021)

Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer
por: Afsari, Bahman, et al.
Publicado: (2021)

IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients
por: He, Jian, et al.
Publicado: (2011)

Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules
por: Wang, Yuxuan, et al.
Publicado: (2023)

An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation
por: Miller, Michelle S., et al.
Publicado: (2019)

An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
por: Cook, Ashley L., et al.
Publicado: (2022)

Sulfation of O-glycans on Mucin-type Proteins From Serous Ovarian Epithelial Tumors
por: Thomsson, Kristina A., et al.
Publicado: (2021)

Incidence and Distribution of UroSEEK Gene Panel in a Multi-institutional Cohort of Bladder Urothelial Carcinoma
por: Eich, Marie-Lisa, et al.
Publicado: (2019)

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
por: Diaz, Luis A., et al.
Publicado: (2012)

Heteroplasmic mitochondrial DNA mutations in normal and tumor cells
por: He, Yiping, et al.
Publicado: (2010)

Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
por: Kim, Kibem, et al.
Publicado: (2014)

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

Patient-oriented gene set analysis for cancer mutation data
por: Boca, Simina M, et al.
Publicado: (2010)

Insertion/Deletion Polymorphism and Other Restriction Fragment Length Polymorphisms in the MCC Gene
por: Miyoshi, Yasuo, et al.
Publicado: (1992)

Re: Article by Natalie Banet and Robert J. Kurman: Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis; Int. J. Gynecol. Pathol. 2015;34:3–8
por: Kurman, Robert J., et al.
Publicado: (2015)

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
por: Sausen, Mark, et al.
Publicado: (2012)

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark
por: Hannibal, Charlotte G., et al.
Publicado: (2022)

Complex renal cysts associated with crizotinib treatment
por: Schnell, Patrick, et al.
Publicado: (2015)

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022)

Genetic Progression and the Waiting Time to Cancer
por: Beerenwinkel, Niko, et al.
Publicado: (2007)

The rapid and highly parallel identification of antibodies with defined biological activities by SLISY
por: Lu, Steve, et al.
Publicado: (2023)

PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity
por: Sur, Surojit, et al.
Publicado: (2015)

The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19
por: Rose, Liam, et al.
Publicado: (2021)

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints
por: Losa, Nicolas L, et al.
Publicado: (2015)

Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021)

The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19
por: Rose, Liam, et al.
Publicado: (2021)

Thiazolidinedione-Based PI3Kα Inhibitors: An Analysis of Biochemical and Virtual Screening Methods
por: Pinson, Jo-Anne, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qtfqqh6vesr77lcp1r8lvtr86k